方法制备大鼠阿霉素肾病模型（肾病组）与正常对照组。
Methods The study set up adriamycin nephropathic model of rats as nephropathic group and compared with that the normal control group.
狭窄的发生率：糖尿病肾病组高于正常对照组（P<0.05）。
Stenosal incidence: It was higher in the diabetic nephropathy group than that in the normal control group (P< 0.05).
同时测定肾小管损伤组儿童尿NAG酶的水平，明显高于肾病组与对照组；
Meanwhile, the urine NAG enzyme in children with renal tubule lesion was significantly higher than that in the nephrosis group and the control.
结果 与对照组相比，第14天时肾病组尿蛋白显著增加（P < 0.01）。
Results Compared to the control rats, 24 h urinary protein of the ADR rats increased significantly at day 14 (P < 0.01).
临床糖尿病肾病组的TC／CC基因型频率和-429C等位基因频率显著低于其它各组；
The frequencies of genotype TC/CC and -429C allele in group CDN were lower than other groups.
方法将82例原发性肾病综合征患者随机分为2组。
Methods 82 patients with primary nephrosis syndrom were randomly divided into two groups.
肾病以一组因肾组织损伤和肾功能受损而导致的症状为特征。
Nephrosis is characterized by a group of symptoms resulting from kidney tissue damage and impaired nephric function.
方法：112例2型糖尿病性肾病患者随机分为①对照组：仅用包括降糖疗法的一般糖尿病性肾病治疗方法；
Methods: 112 cases of type 2 diabetic nephropathy were divided into two groups, involved in a randomized control clinical trial.
方法：对48例原发性膜性肾炎肾病综合征分为治疗组和对照组。
Methods: Divide 48 cases of primary membranous nephritis and kidney disease syndrome into "cure group" and "contrast group".
目的建立和优化终末期肾病患者血清蛋白质组研究的双向电泳及相关技术，并与正常血清蛋白图谱比较。
Objective To establish and optimize the two-dimensional gel electrophoresis technical platform for the blood serum proteome research in patients with end stage renal disease(ESRD).
目的：探讨原发性肾病综合征（PNS）患者红细胞CR1密度相关基因组多态性及数量表达、黏附活性与临床疗效的关系。
Objective: To study the clinical effect and erythrocytes CR1 genomic density and quantitative expression, adhesive active in primary nephrosis syndrome(PNS).
方法：将60例早期糖尿病肾病患者随机分为治疗组与对照组，每组30例。
Methods: 60 cases of early phase diabetic nephropathy patients were divided randomly into two groups, 30 in the therapeutic group and 30 in the control group.
结果：对照组大鼠24只，糖尿病模型组大鼠24只，糖尿病肾病待定组大鼠5只全部进入结果分析。
RESULTS: a total of 24 rats in the control group, 24 rats in the diabetic model group and 5 rats in the diabetic nephropathy group were involved in the result analysis.
方法将60例慢性尿酸性肾病患者随机分为治疗组和对照组。
Methods Divide 60 cases of chronic uric acid nephropathy into "cure group" and "contrast group".
方法对36例糖尿病肾病合并顽固性高血压患者随机分为治疗组和对照组，观察两组治疗前后降压情况、副作用和实验证据变化。
Methods There 36 diabetic nephropathy patients complicated with refractory hypertension were treated with two different therapies and the results were observed before and after the treatment.
结果：健康教育组测试成绩显著高于教育前，而对照组的成绩无显著变化；糖尿病肾病的发生率显著低于对照组。
Performance record was contrasted between before and after heath education and incidence rate of degenerative nephritis was contrasted to control group.
方法：检测33例糖尿病肾病患者及30例健康体检对照组血浆纤溶酶原激活物抑制物-1（PAI-1），观察检测结果。
Method Plasminogen activator inhibitor-1(PAI-1) in 33 cases of diabetic nephropathy and 30 healthy controls were detected, and the test results were observed.
方法选择糖尿病肾病伴有轻度高尿酸血症患者140例，随机分为治疗组72例和对照组68例。
Methods 140 diabetic patients with mild hyperuricemia were randomly divided into treatment group(72 cases) and control group(68 cases).
方法：回顾性分析80例糖尿病肾病患者，按照入院时间先后将其分为对照组和观察组，每组各40例。
Methods: A retrospective analysis of 80 patients with diabetic nephropathy, who were divided into control group and observation group with 40 patients for each.
方法：将入选的糖尿病肾病病人随机分为对照组和治疗组。
Methods: The patients who were collected were randomly divided into two groups: control group and treatment group.
为研究IBV变异株的基因组及其变异特征，本实验通过基因扩增拼接的方法获得了肾病变型毒株JH06111的全基因组序列。
To study the genomic characteristics of IBV variant isolate, we obtained the full genome sequences of nephropathogenic JH06111 by amplifying, cloning and sequencing of its cDNA.
方法将108例原发性肾病综合征患者随机分为治疗组(54例)和对照组(54例)。
Methods One hundred and eight cases of primary nephrotic syndrome were randomly divided into treatment group (54 cases) and control group (54 cases).
方法：50例糖尿病肾病患者，随机分为参芪糖脉康治疗组30例，对照组20例。
Methods:50 patients of DN were divided randomly into SQTMK grope(30cases) and control grope(20cases).
肾病综合症患儿血清锌、铜、钙均较低，与正常对照组比较差异有显著性P。
Meanwhile, the immune indices of children with NS were observed and compared with children whose zinc in serum was lower.
方法：建立SD大鼠糖尿病肾病模型后，随机分为四组：模型组、西药组、川芎嗪高、低剂量组，另设切除右肾的SD大鼠作为空白对照，共五组动物。
Method:After creating the DN models of SD rats, divided the animals into four groups randomly:including model group, west medicine group, Ligustrazine(high and low-dosage)groups.
试验组由90名无并发冠心病、高血压、糖尿病、晚期慢性肾病的RA患者组成。
The study group consisted of 90 patients with RA, without clinically relevant coronary heart disease, hypertension, diabetes, advanced chronic kidney disease.
巨量白蛋白尿的患者组，其肾病进展的危险因素与微量白蛋白尿组相似，其进展的患者肾小球滤过率较低（GFRs）且诊断有心血管疾病或心力衰竭。
The macroalbuminuria group had risk factors similar to the microalbuminuria group, and had lower glomerular filtration rates (GFRs) and a diagnosis of cardiovascular disease or heart failure.
巨量白蛋白尿的患者组，其肾病进展的危险因素与微量白蛋白尿组相似，其进展的患者肾小球滤过率较低（GFRs）且诊断有心血管疾病或心力衰竭。
The macroalbuminuria group had risk factors similar to the microalbuminuria group, and had lower glomerular filtration rates (GFRs) and a diagnosis of cardiovascular disease or heart failure.
应用推荐